Joincare Pharmaceutical Group Industry Co Ltd (Joincare Pharma) develops, manufactures, and supplies pharmaceutical products. The company offers products such as health products, prescription drugs, inhalation preparation, and others. The company operates through chemical and detection reagents, traditional Chinese medicine, health products, chemical API, and monoclonal antibody business segments. The company provides active pharmaceutical ingredients (API) such as cephalosporin series, statin series and carbapenem series. Joincare Pharma is headquartered in Shenzhen, Guangdong, China.
Headquarters
China
Address
Joincare Pharmaceutical Group Plaza, No.17 Langshan Road, North Section, High-Tech Zone, Nanshan District, Shenzhen, Guangdong, 518057
Website
www.joincare.com
Telephone
86 755 86252656
No of Employees
14,365
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
600380 (SHA)
Revenue (2022)
$2.4B
-2.9%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-4%
(2022 vs 2021)
Market Cap*
$3.0B
Net Profit Margin (2022)
XYZ
-1.1%
(2022 vs 2021)
* As of and is in US$
Joincare Pharmaceutical Group Industry Co Ltd premium industry data and analytics
Products and Services
| Products |
|---|
| Inhalation products |
| Gastrointestinal Series Products |
| Assisted Reproductive Products |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Contracts/Agreements | In January, the company entered into a partnership with Luye Pharma Group to develop and commercialize BA2101 in the Chinese Mainland to treat respiratory diseases such as asthma and COPD. |
| 2022 | Contracts/Agreements | In December, the company entered into a framework agreement with Livzon Pharma to establish a joint venture company by investing RMB10 million. |
| 2022 | Stock Listings/IPO | In June, the company announced its plans to list on the SIX Swiss stock exchange. |
Competitor Comparison
| Key Parameters | Joincare Pharmaceutical Group Industry Co Ltd | Huadong Medicine Co Ltd | Apeloa Pharmaceutical Co Ltd | Yabao Pharmaceutical Group Co Ltd | Beijing Tide Pharmaceutical Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Shenzhen | Hangzhou | Jinhua | Beijing | Beijing |
| State/Province | Guangdong | Zhejiang | Zhejiang | Beijing | Beijing |
| No. of Employees | 14,365 | 14,061 | 7,208 | 4,367 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Zhu Baoguo | Chairman | Executive Board | 2001 | 61 |
| Liu Guangxia | Vice Chairman | Executive Board | 2001 | 54 |
| Qiu Qingfeng | Chief Financial Officer; Director; Vice Chairman | Executive Board | 2020 | 52 |
| Yu Xiong | President; Director | Executive Board | 2021 | 62 |
| Lin Nanqi | Vice President; Director | Executive Board | 2019 | 41 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward